160 related articles for article (PubMed ID: 31901745)
1. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
Zaręba P; Gryzło B; Malawska K; Sałat K; Höfner GC; Nowaczyk A; Fijałkowski Ł; Rapacz A; Podkowa A; Furgała A; Żmudzki P; Wanner KT; Malawska B; Kulig K
Eur J Med Chem; 2020 Feb; 188():111920. PubMed ID: 31901745
[TBL] [Abstract][Full Text] [Related]
2. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
Zaręba P; Sałat K; Höfner GC; Łątka K; Bajda M; Latacz G; Kotniewicz K; Rapacz A; Podkowa A; Maj M; Jóźwiak K; Filipek B; Wanner KT; Malawska B; Kulig K
Eur J Med Chem; 2021 Oct; 221():113512. PubMed ID: 34015586
[TBL] [Abstract][Full Text] [Related]
3. Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic Activity.
Gryzło B; Zaręba P; Malawska K; Mazur G; Rapacz A; Ła Tka K; Höfner GC; Latacz G; Bajda M; Sałat K; Wanner KT; Malawska B; Kulig K
ACS Chem Neurosci; 2021 Aug; 12(16):3073-3100. PubMed ID: 34347423
[TBL] [Abstract][Full Text] [Related]
4. Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
Schaffert ES; Höfner G; Wanner KT
Bioorg Med Chem; 2011 Nov; 19(21):6492-504. PubMed ID: 21940173
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
Kragler A; Höfner G; Wanner KT
Eur J Med Chem; 2008 Nov; 43(11):2404-11. PubMed ID: 18395300
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological properties of new GABA uptake inhibitors.
Sałat K; Więckowska A; Więckowski K; Höfner GC; Kamiński J; Wanner KT; Malawska B; Filipek B; Kulig K
Pharmacol Rep; 2012; 64(4):817-33. PubMed ID: 23087134
[TBL] [Abstract][Full Text] [Related]
7. Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
Hack S; Wörlein B; Höfner G; Pabel J; Wanner KT
Eur J Med Chem; 2011 May; 46(5):1483-98. PubMed ID: 21353350
[TBL] [Abstract][Full Text] [Related]
8. Novel parent structures for inhibitors of the murine GABA transporters mGAT3 and mGAT4.
Kragler A; Höfner G; Wanner KT
Eur J Pharmacol; 2005 Sep; 519(1-2):43-7. PubMed ID: 16111674
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
Quandt G; Höfner G; Wanner KT
Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
Tóth K; Höfner G; Wanner KT
Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
[TBL] [Abstract][Full Text] [Related]
11. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
Kowalczyk P; Sałat K; Höfner GC; Guzior N; Filipek B; Wanner KT; Kulig K
Bioorg Med Chem; 2013 Sep; 21(17):5154-67. PubMed ID: 23859778
[TBL] [Abstract][Full Text] [Related]
12. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
[TBL] [Abstract][Full Text] [Related]
13. Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
Hauke TJ; Höfner G; Wanner KT
Bioorg Med Chem; 2019 Jan; 27(1):144-152. PubMed ID: 30503411
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
Steffan T; Renukappa-Gutke T; Höfner G; Wanner KT
Bioorg Med Chem; 2015 Mar; 23(6):1284-306. PubMed ID: 25698617
[TBL] [Abstract][Full Text] [Related]
15. Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.
Kern FT; Wanner KT
ChemMedChem; 2015 Feb; 10(2):396-410. PubMed ID: 25369775
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a series of N-alkylated imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
Kerscher-Hack S; Renukappa-Gutke T; Höfner G; Wanner KT
Eur J Med Chem; 2016 Nov; 124():852-880. PubMed ID: 27654218
[TBL] [Abstract][Full Text] [Related]
17. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
Lutz T; Wein T; Höfner G; Wanner KT
ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
[TBL] [Abstract][Full Text] [Related]
18. Hypoalgesia in mice lacking GABA transporter subtype 1.
Xu YF; Cai YQ; Cai GQ; Jiang J; Sheng ZJ; Wang ZG; Fei J
J Neurosci Res; 2008 Feb; 86(2):465-70. PubMed ID: 17918738
[TBL] [Abstract][Full Text] [Related]
19. GABA transporter mGat4 is involved in multiple neural functions in mice.
Ying Y; Liu W; Wang H; Shi J; Wang Z; Fei J
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119740. PubMed ID: 38697303
[TBL] [Abstract][Full Text] [Related]
20. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.
Nowaczyk A; Fijałkowski Ł; Zaręba P; Sałat K
J Mol Graph Model; 2018 Oct; 85():171-181. PubMed ID: 30219588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]